SYK - Stryker Corporation

NYSE - NYSE Delayed Price. Currency in USD
198.00
+0.86 (+0.44%)
At close: 4:01PM EDT

198.00 0.00 (0.00%)
After hours: 5:46PM EDT

Stock chart is not supported by your current browser
Previous Close197.14
Open196.06
Bid183.30 x 1000
Ask210.00 x 1000
Day's Range196.06 - 198.71
52 Week Range144.75 - 198.75
Volume896,876
Avg. Volume1,493,365
Market Cap73.788B
Beta (3Y Monthly)1.04
PE Ratio (TTM)21.20
EPS (TTM)9.34
Earnings DateApr 23, 2019
Forward Dividend & Yield2.08 (1.07%)
Ex-Dividend Date2019-03-28
1y Target Est193.50
Trade prices are not sourced from all markets
  • GlobeNewswire5 hours ago

    Stryker to host conference call on April 23, 2019

    Stryker (SYK) announced that it will host a conference call on Tuesday, April 23, 2019 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2019 and provide an operational update. To participate in the conference call dial (877) 702-4565 (domestic) or (647) 689-5532 (international) and be prepared to provide conference ID number 4854803 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com.

  • Abbott's (ABT) HeartMate 3 Pump Study Shows Favorable Results
    Zacks8 hours ago

    Abbott's (ABT) HeartMate 3 Pump Study Shows Favorable Results

    The use of Abbott's (ABT) HeartMate 3 pump can efficiently prolong life -term and improve the quality of life for advanced heart failure patients.

  • 3 Reasons Growth Investors Will Love Stryker (SYK)
    Zacks10 hours ago

    3 Reasons Growth Investors Will Love Stryker (SYK)

    Stryker (SYK) is well positioned to outperform the market, as it exhibits above-average growth in financials.

  • GlobeNewswireyesterday

    Stryker announces Annual Meeting of Shareholders

    Kalamazoo, Michigan, March 20, 2019 -- Stryker (NYSE:SYK) announced its 2019 Annual Meeting of Shareholders is scheduled as follows: May 1, 2019 – 2:00 p.m. Eastern.

  • Stryker (SYK) Scales a New 52-Week High on Solid Prospects
    Zacksyesterday

    Stryker (SYK) Scales a New 52-Week High on Solid Prospects

    The key growth-driving factor for Stryker (SYK) in the past year has been increasing net sales from each of its three major business segments.

  • Stryker (SYK) Hits Fresh High: Is There Still Room to Run?
    Zacksyesterday

    Stryker (SYK) Hits Fresh High: Is There Still Room to Run?

    Stryker (SYK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

  • Barrons.comyesterday

    Sen. Jack Reed Sells Apple, Xilinx, and Qualcomm Stock

    Sen. John “Jack” Reed disclosed Tuesday that he sold (AAPL) stock and shares of some other high-profile tech names in late February. The Rhode Island Democrat, who serves on several committees, including Appropriations, Armed Services, and Banking, Housing, and Urban Affairs, sold Apple stock (ticker: AAPL) and shares of (XLNX) (XLNX) and (QCOM) (QCOM). The sales disclosed were all made on Feb. 28, according to a regulatory form Reed filed.

  • 3 Blue-Chip Stocks That Just Hit 52-Week Highs: Are They Buys?
    Motley Fool2 days ago

    3 Blue-Chip Stocks That Just Hit 52-Week Highs: Are They Buys?

    Two medical-device makers and one big drugmaker are on a roll. But can their momentum continue?

  • 7 GARP Stocks to Scoop Up for Maximum Returns
    Zacks3 days ago

    7 GARP Stocks to Scoop Up for Maximum Returns

    If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.

  • Intuitive Surgical da Vinci SP Gets FDA Nod, Prospects Bright
    Zacks3 days ago

    Intuitive Surgical da Vinci SP Gets FDA Nod, Prospects Bright

    Intuitive Surgical (ISRG) fortifies its foothold in the global robotic-surgery market.

  • Why Stryker Corporation (NYSE:SYK) Could Be Worth Watching
    Simply Wall St.3 days ago

    Why Stryker Corporation (NYSE:SYK) Could Be Worth Watching

    Let's talk about the popular Stryker Corporation (NYSE:SYK). The company's shares led the NYSE gainers with a relatively large price hike in the past couple of weeks. With many analystsRead More...

  • Stryker Buys Israel-Based OrthoSpace, Strengthens MedSurg
    Zacks6 days ago

    Stryker Buys Israel-Based OrthoSpace, Strengthens MedSurg

    Strong international presence and an acquisition-driven strategy are likely to fortify Stryker's (SYK) footprint in the global MedTech space.

  • Here's Why You Should Invest in Stryker (SYK) Stock Right Now
    Zacks7 days ago

    Here's Why You Should Invest in Stryker (SYK) Stock Right Now

    Stryker (SYK) makes a few lucrative acquisitions in recent times.

  • Nevro (NVRO) Q4 Loss Wider Than Expected, Revenues Beat
    Zacks7 days ago

    Nevro (NVRO) Q4 Loss Wider Than Expected, Revenues Beat

    Nevro's (NVRO) solid domestic and international performance aids Q4 results.

  • GlobeNewswire7 days ago

    Stryker acquires OrthoSpace, Ltd.

    Stryker (SYK) announced today it has completed the acquisition of OrthoSpace, Ltd., a privately held company founded in 2009 and headquartered in Caesarea, Israel, in an all cash transaction for an upfront payment of $110 million and future milestone payments of up to an additional $110 million. OrthoSpace’s product portfolio provides a highly differentiated technology for the treatment of massive irreparable rotator cuff tears. The technology has a long clinical history with over 20,000 patients treated across 30 countries.

  • RTI Surgical Buys Paradigm Spine, Adds Coflex to Portfolio
    Zacks8 days ago

    RTI Surgical Buys Paradigm Spine, Adds Coflex to Portfolio

    RTI Surgical's (RTIX) acquisition of Paradigm Spine aligns with the former's goal of expanding its spine portfolio.

  • Markit9 days ago

    See what the IHS Markit Score report has to say about Stryker Corp.

    Stryker Corp NYSE:SYKView full report here! Summary * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is extremely low for SYK with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting SYK. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold SYK had net inflows of $3.54 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Varian & Tata Trust Tie Up to Boost Radiotherapy in India
    Zacks9 days ago

    Varian & Tata Trust Tie Up to Boost Radiotherapy in India

    Varian's (VAR) three-year deal with Tata Trust is likely to fortify its foothold in the Asia-Pacific radiotherapy space.

  • Benzinga10 days ago

    RBC Lifts Stryker Price Target, Says Medtech Company Positioned For Growth

    Meetings with Stryker Corporation’s (NYSE: SYK ) CEO inspired greater confidence in the company’s topline growth being sustainable into the foreseeable future, as well as near- and medium-term cost-saving ...

  • Zacks.com featured highlights include: Oaktree Capital, Synopsys, Starbucks, Stryker and Ares Capital
    Zacks13 days ago

    Zacks.com featured highlights include: Oaktree Capital, Synopsys, Starbucks, Stryker and Ares Capital

    Zacks.com featured highlights include: Oaktree Capital, Synopsys, Starbucks, Stryker and Ares Capital

  • The World's Top 10 Health Care Companies (UNH, MDT)
    Investopedia14 days ago

    The World's Top 10 Health Care Companies (UNH, MDT)

    Discover the world's top 10 health care companies according to market capitalization, including a brief summary of each.

  • Zacks.com featured highlights include: Core-Mark, Progressive, Casey???s, Stryker and Intuit
    Zacks14 days ago

    Zacks.com featured highlights include: Core-Mark, Progressive, Casey???s, Stryker and Intuit

    Zacks.com featured highlights include: Core-Mark, Progressive, Casey???s, Stryker and Intuit

  • Moving Average Crossover Alert: Stryker
    Zacks14 days ago

    Moving Average Crossover Alert: Stryker

    Stryker Corporation (SYK) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

  • Impressive Sales Growth Makes These 5 Stocks Worth Buying
    Zacks14 days ago

    Impressive Sales Growth Makes These 5 Stocks Worth Buying

    Sales growth is an important metric for any company as it is a vital part of growth projections and is instrumental in strategic decision-making.

  • Robot-assisted technology is helping surgeons during knee replacements
    Yahoo Finance Video15 days ago

    Robot-assisted technology is helping surgeons during knee replacements

    Stryker Joint Replacement is using its knee surgery technology to help surgeons “hit the target of where implants should be with accuracy and precision.” Yahoo Finance’s Alexis Christoforous speaks to Robert Cohen, Stryker Joint Replacement Chief Technology Officer.